Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Breast Cancer Research : BCR|February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancerCarsten Denkert, Jens Huober, Sibylle Loibl, et al.
Annals of Surgical Oncology|April 18, 2014
Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44)Bernd Gerber, Gunter von Minckwitz, Holger Eidtmann, et al.
Breast Cancer Research : BCR|September 24, 2024
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancerBruno Valentin Sinn, Katharina Sychra, Michael Untch, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2019
Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node-positive studyAurelia Noske, Volker Möbus, Karsten Weber, et al.
Breast Cancer Research : BCR|March 28, 2023
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudyPauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, et al.
NPJ Breast Cancer|April 7, 2023
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapyJens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, et al.
JAMA Oncology|May 19, 2022
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical TrialJens-Uwe Blohmer, Theresa Link, Mattea Reinisch, et al.
BMC Cancer|October 4, 2022
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapyJonas Leichsenring, Valentina Vladimirova, Christine Solbach, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controlsFrédéric Amant, Valentina Nekljudova, Charlotte Maggen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast CancerBarbara Ingold Heppner, Michael Untch, Carsten Denkert, et al.
Pageof 13